Literature DB >> 10671434

Sympathoadrenal hyperactivity and neuroleptic malignant syndrome.

N A Qureshi, T A Al-Habeeb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10671434     DOI： 10.1176/appi.ajp.157.2.310-a

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  1 in total

1.  Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia.

Authors:  Minfeng Cheng; Huaying Gu; Liangrong Zheng; Houliang Wang; Zhiyong Zhong; Shenglin Wen
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-29       Impact factor: 2.570
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.